{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T18:22:43Z","timestamp":1792174963284,"version":"4.4.0"},"reference-count":129,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","dldjournalonline.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Digestive and Liver Disease"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.dld.2024.05.004","type":"journal-article","created":{"date-parts":[[2024,5,20]],"date-time":"2024-05-20T20:37:53Z","timestamp":1716237473000},"page":"1971-1979","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Microbiota modulation in disorders of gut-brain interaction"],"prefix":"10.1016","volume":"56","author":[{"given":"Giovanni","family":"Marasco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cesare","family":"Cremon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Raffaella","family":"Barbaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Bianco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Stanghellini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Barbara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.dld.2024.05.004_bib0001","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2016.02.031","article-title":"Bowel disorders","volume":"150","author":"Lacy","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2024.05.004_bib0002","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1016\/S0140-6736(20)32115-2","article-title":"Functional gastrointestinal disorders: advances in understanding and management","volume":"396","author":"Black","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.dld.2024.05.004_bib0003","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1053\/j.gastro.2020.04.014","article-title":"Worldwide prevalence and burden of functional gastrointestinal disorders, results of rome foundation global study","volume":"160","author":"Sperber","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2024.05.004_bib0004","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1111\/apt.12942","article-title":"Conducting multinational, cross-cultural research in the functional gastrointestinal disorders: issues and recommendations. A Rome Foundation working team report","volume":"40","author":"Sperber","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2024.05.004_bib0005","doi-asserted-by":"crossref","first-page":"e14566","DOI":"10.1111\/nmo.14566","article-title":"A comparative study of disorders of gut\u2013brain interaction in Western Europe and Asia based on the Rome foundation global epidemiology study","volume":"35","author":"Hreinsson","year":"2023","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.dld.2024.05.004_bib0006","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1053\/j.gastro.2016.02.028","article-title":"The intestinal microenvironment and functional gastrointestinal disorders","volume":"150","author":"Barbara","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2024.05.004_bib0007","doi-asserted-by":"crossref","DOI":"10.1002\/ueg2.12259","article-title":"Functional bowel disorders with diarrhoea: clinical guidelines of the United European Gastroenterology and European Society for Neurogastroenterology and Motility","volume":"10","author":"Savarino","year":"2022","journal-title":"United European Gastroenterol J"},{"key":"10.1016\/j.dld.2024.05.004_bib0008","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11113102","article-title":"Pathophysiology and clinical management of bile acid diarrhea","volume":"11","author":"Marasco","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.dld.2024.05.004_bib0009","article-title":"Inflammatory and microbiota-related regulation of the intestinal epithelial barrier","volume":"8","author":"Barbara","year":"2021","journal-title":"Front Nutr"},{"key":"10.1016\/j.dld.2024.05.004_bib0010","article-title":"Corrigendum: inflammatory and Microbiota-Related Regulation of the Intestinal Epithelial Barrier","volume":"8","author":"Barbara","year":"2021","journal-title":"Front Nutr"},{"key":"10.1016\/j.dld.2024.05.004_bib0011","article-title":"Role of inflammation in pediatric irritable bowel syndrome","author":"Di Nardo","year":"2022","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.dld.2024.05.004_bib0012","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1136\/gutjnl-2016-312456","article-title":"Functional variants in the sucrase-isomaltase gene associate with increased risk of irritable bowel syndrome","volume":"67","author":"Henstr\u00f6m","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.dld.2024.05.004_bib0013","article-title":"Gut microbiota signatures and modulation in irritable bowel syndrome","volume":"1","author":"Marasco","year":"2022","journal-title":"Microbiome Res Rep"},{"key":"10.1016\/j.dld.2024.05.004_bib0014","first-page":"1","article-title":"Meta-analysis: post-COVID-19 functional dyspepsia and irritable bowel syndrome","volume":"00","author":"Marasco","year":"2023","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2024.05.004_bib0015","doi-asserted-by":"crossref","first-page":"147","DOI":"10.14309\/ajg.0000000000001541","article-title":"Prevalence of gastrointestinal symptoms in severe acute respiratory syndrome coronavirus 2 infection: results of the prospective controlled multinational GI-COVID-19 study","volume":"117","author":"Marasco","year":"2022","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2024.05.004_bib0016","article-title":"Post COVID-19 irritable bowel syndrome","author":"Marasco","year":"2022","journal-title":"Gut"},{"key":"10.1016\/j.dld.2024.05.004_bib0017","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1053\/j.gastro.2016.12.039","article-title":"Prevalence, risk factors, and outcomes of irritable bowel syndrome after infectious enteritis: a systematic review and meta-analysis","volume":"152","author":"Klem","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2024.05.004_bib0018","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/2534975","article-title":"Gastrointestinal bleeding in COVID-19 patients: a systematic review with meta-analysis","volume":"2021","author":"Marasco","year":"2021","journal-title":"Can J Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2024.05.004_bib0019","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.dld.2022.11.015","volume":"55","author":"Barbara","year":"2023","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.dld.2024.05.004_bib0020","doi-asserted-by":"crossref","first-page":"G52","DOI":"10.1152\/ajpgi.00338.2016","article-title":"Irritable bowel syndrome: a gut microbiota-related disorder?","volume":"312","author":"Bhattarai","year":"2016","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.dld.2024.05.004_bib0021","article-title":"Dysbiosis of the gut microbiota in disease","volume":"26","author":"Carding","year":"2015","journal-title":"Microb Ecol Health Dis"},{"key":"10.1016\/j.dld.2024.05.004_bib0022","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1053\/j.gastro.2018.07.011","article-title":"Rome foundation working team report on post-infection irritable bowel syndrome","volume":"156","author":"Barbara","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2024.05.004_bib0023","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1002\/ibd.21830","article-title":"Differences of small intestinal bacteria populations in adults and children with\/without celiac disease: effect of age, gluten diet, and disease","volume":"18","author":"Nistal","year":"2012","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.dld.2024.05.004_bib0024","doi-asserted-by":"crossref","first-page":"e14372","DOI":"10.1111\/nmo.14372","article-title":"Role of the duodenal microbiota in functional dyspepsia","volume":"34","author":"Brown","year":"2022","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.dld.2024.05.004_bib0025","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1136\/gutjnl-2016-312574","article-title":"Dyspepsia and the microbiome: time to focus on the small intestine","volume":"66","author":"Zhong","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.dld.2024.05.004_bib0026","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.cell.2014.03.011","article-title":"Role of the microbiota in immunity and inflammation","volume":"157","author":"Belkaid","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.dld.2024.05.004_bib0027","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1038\/nri2850","article-title":"The immune system and the gut microbiota: friends or foes?","volume":"10","author":"Cerf-Bensussan","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.dld.2024.05.004_bib0028","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/978-0-387-09550-9_2","article-title":"The commensal microbiology of the gastrointestinal tract","volume":"635","author":"Manson","year":"2008","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.dld.2024.05.004_bib0029","article-title":"Inflammatory and microbiota-related regulation of the intestinal epithelial barrier","volume":"8","author":"Barbara","year":"2021","journal-title":"Front Nutr"},{"key":"10.1016\/j.dld.2024.05.004_bib0030","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1136\/gutjnl-2016-312377","article-title":"Gut microbiota, metabolome and immune signatures in patients with uncomplicated diverticular disease","volume":"66","author":"Barbara","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.dld.2024.05.004_bib0031","doi-asserted-by":"crossref","first-page":"2674","DOI":"10.3390\/nu12092674","article-title":"Probiotics, prebiotics and other dietary supplements for gut microbiota modulation in celiac disease patients","volume":"12","author":"Marasco","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/j.dld.2024.05.004_bib0032","article-title":"Gut microbiota signatures and clinical manifestations in celiac disease children at onset: a pilot study","author":"Di Biase","year":"2020","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2024.05.004_bib0033","doi-asserted-by":"crossref","first-page":"e14615","DOI":"10.1111\/nmo.14615","article-title":"The role of microbiota and its modulation in colonic diverticular disease","volume":"35","author":"Marasco","year":"2023","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.dld.2024.05.004_bib0034","doi-asserted-by":"crossref","first-page":"17","DOI":"10.14309\/ajg.0000000000001036","article-title":"ACG Clinical Guideline: management of Irritable Bowel Syndrome","volume":"116","author":"Lacy","year":"2021","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2024.05.004_bib0035","article-title":"Efficacy of prebiotics and probiotics for functional dyspepsia: a systematic review and meta-analysis","volume":"99","author":"Zhang","year":"2020","journal-title":"Medicine"},{"key":"10.1016\/j.dld.2024.05.004_bib0036","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/j.1572-0241.2002.05428.x","article-title":"Antibiotics increase functional abdominal symptoms","volume":"97","author":"Maxwell","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2024.05.004_bib0037","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1111\/apt.15001","article-title":"Systematic review with meta-analysis: the efficacy of prebiotics, probiotics, synbiotics and antibiotics in irritable bowel syndrome","volume":"48","author":"Ford","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2024.05.004_bib0038","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1053\/j.gastro.2019.03.049","article-title":"Gut microbiota in patients with irritable bowel syndrome\u2014a systematic review","volume":"157","author":"Pittayanon","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2024.05.004_bib0039","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1053\/j.gastro.2019.11.301","article-title":"Differences in fecal microbiomes and metabolomes of people with vs without irritable bowel syndrome and bile acid malabsorption","volume":"158","author":"Jeffery","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2024.05.004_bib0040","doi-asserted-by":"crossref","DOI":"10.14309\/ctg.0000000000000012","article-title":"Alterations of gut microbiota in patients with irritable bowel syndrome based on 16s rRNA-targeted sequencing: a systematic review","volume":"10","author":"Duan","year":"2019","journal-title":"Clin Transl Gastroenterol"},{"key":"10.1016\/j.dld.2024.05.004_bib0041","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1053\/j.gastro.2016.09.049","article-title":"Identification of an intestinal microbiota signature associated with severity of irritable bowel syndrome","volume":"152","author":"Tap","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2024.05.004_bib0042","doi-asserted-by":"crossref","first-page":"G417","DOI":"10.1152\/ajpgi.00044.2015","article-title":"Molecular characterization of the intestinal microbiota in patients with and without abdominal bloating","volume":"310","author":"Kulka","year":"2016","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.dld.2024.05.004_bib0043","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s40168-022-01450-5","article-title":"Multi-omics profiles of the intestinal microbiome in irritable bowel syndrome and its bowel habit subtypes","volume":"11","author":"Jacobs","year":"2023","journal-title":"Microbiome"},{"key":"10.1016\/j.dld.2024.05.004_bib0044","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2022.910568","article-title":"The role of gastrointestinal microbiota in functional dyspepsia: a review","volume":"13","author":"Zhou","year":"2022","journal-title":"Front Physiol"},{"key":"10.1016\/j.dld.2024.05.004_bib0045","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1152\/ajpgi.2001.280.3.G368","article-title":"Influence of microbial species on small intestinal myoelectric activity and transit in germ-free rats","volume":"280","author":"Husebye","year":"2001","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.dld.2024.05.004_bib0046","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1126\/science.291.5505.881","article-title":"Molecular analysis of commensal host-microbial relationships in the intestine","volume":"291","author":"Hooper","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.dld.2024.05.004_bib0047","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0164731","article-title":"Characterization of Microbiota in Children with Chronic Functional Constipation","volume":"11","author":"De Meij","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.dld.2024.05.004_bib0048","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-10663-w","article-title":"Unveiling the gut microbiota composition and functionality associated with constipation through metagenomic analyses","volume":"7","author":"Mancabelli","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.dld.2024.05.004_bib0049","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1093\/gastro\/goab035","article-title":"Role of gut microbiota in functional constipation","volume":"9","author":"Zhang","year":"2021","journal-title":"Gastroenterol Rep (Oxf)"},{"key":"10.1016\/j.dld.2024.05.004_bib0050","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.gtc.2021.03.003","article-title":"Emerging Role of the Gut Microbiome in Irritable Bowel Syndrome","volume":"50","author":"Singh","year":"2021","journal-title":"Gastroenterol Clin North Am"},{"key":"10.1016\/j.dld.2024.05.004_bib0051","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1016\/j.cgh.2015.02.043","article-title":"The Science, Evidence, and Practice of Dietary Interventions in Irritable Bowel Syndrome","volume":"13","author":"Lacy","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2024.05.004_bib0052","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1007\/s00394-015-0922-1","article-title":"Does a diet low in FODMAPs reduce symptoms associated with functional gastrointestinal disorders? A comprehensive systematic review and meta-analysis","volume":"55","author":"Marsh","year":"2016","journal-title":"Eur J Nutr"},{"key":"10.1016\/j.dld.2024.05.004_bib0053","doi-asserted-by":"crossref","DOI":"10.3390\/nu11092162","article-title":"The Dietary Management of Patients with Irritable Bowel Syndrome: a Narrative Review of the Existing and Emerging Evidence","volume":"11","author":"Algera","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/j.dld.2024.05.004_bib0054","article-title":"Mechanisms underlying food-related symptoms in disorders of gut-brain interaction: course ahead in research and clinical practice","volume":"62\u201363","author":"Colomier","year":"2023","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1016\/j.dld.2024.05.004_bib0055","doi-asserted-by":"crossref","first-page":"370","DOI":"10.3390\/nu16030370","article-title":"The Role of the FODMAP Diet in IBS","volume":"16","author":"Bertin","year":"2024","journal-title":"Nutrients"},{"key":"10.1016\/j.dld.2024.05.004_bib0056","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1038\/s41395-018-0195-4","article-title":"A systematic review and meta-analysis evaluating the efficacy of a gluten-free diet and a low FODMAPs diet in treating symptoms of irritable bowel syndrome","volume":"113","author":"Dionne","year":"2018","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2024.05.004_bib0057","doi-asserted-by":"crossref","first-page":"3505","DOI":"10.1007\/s00394-021-02620-1","article-title":"Efficacy of a low-FODMAP diet in adult irritable bowel syndrome: a systematic review and meta-analysis","volume":"60","author":"van Lanen","year":"2021","journal-title":"Eur J Nutr"},{"key":"10.1016\/j.dld.2024.05.004_bib0058","article-title":"Two microbiota subtypes identified in irritable bowel syndrome with distinct responses to the low FODMAP diet","author":"Vervier","year":"2021","journal-title":"Gut"},{"key":"10.1016\/j.dld.2024.05.004_bib0059","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s10620-017-4893-3","article-title":"Exploring gut microbiota composition as an indicator of clinical response to dietary FODMAP restriction in patients with irritable bowel syndrome","volume":"63","author":"Valeur","year":"2018","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.dld.2024.05.004_bib0060","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1136\/gutjnl-2016-313128","article-title":"Multivariate modelling of faecal bacterial profiles of patients with IBS predicts responsiveness to a diet low in FODMAPs","volume":"67","author":"Bennet","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.dld.2024.05.004_bib0061","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1093\/ajcn\/nqab005","volume":"113","author":"Zhang","year":"2021","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.dld.2024.05.004_bib0062","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/j.1365-277X.2011.01162.x","article-title":"Comparison of symptom response following advice for a diet low in fermentable carbohydrates (FODMAPs) versus standard dietary advice in patients with irritable bowel syndrome","volume":"24","author":"Staudacher","year":"2011","journal-title":"J Hum Nutr Diet"},{"key":"10.1016\/j.dld.2024.05.004_bib0063","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2016.10.043","article-title":"A Dietary fiber-deprived gut microbiota degrades the colonic mucus barrier and enhances pathogen susceptibility","author":"Desai","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.dld.2024.05.004_bib0064","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1038\/ajg.2013.63","article-title":"Fiber and functional gastrointestinal disorders","volume":"108","author":"Eswaran","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2024.05.004_bib0065","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1136\/gutjnl-2021-324598","article-title":"British Society of Gastroenterology guidelines on the management of irritable bowel syndrome","volume":"70","author":"Vasant","year":"2021","journal-title":"Gut"},{"key":"10.1016\/j.dld.2024.05.004_bib0066","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1093\/jcag\/gwy071","article-title":"Canadian Association of Gastroenterology Clinical Practice guideline for the management of irritable bowel syndrome (IBS)","volume":"2","author":"Moayyedi","year":"2019","journal-title":"J Can Assoc Gastroenterol"},{"key":"10.1016\/j.dld.2024.05.004_bib0067","doi-asserted-by":"crossref","first-page":"17","DOI":"10.14309\/ajg.0000000000001036","article-title":"ACG clinical guideline: management of irritable bowel syndrome","volume":"116","author":"Lacy","year":"2021","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2024.05.004_bib0068","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1053\/j.gastro.2022.04.017","article-title":"AGA clinical practice guideline on the pharmacological management of irritable bowel syndrome with diarrhea","volume":"163","author":"Lembo","year":"2022","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2024.05.004_bib0069","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1053\/j.gastro.2022.04.016","article-title":"AGA clinical practice guideline on the pharmacological management of irritable bowel syndrome with constipation","volume":"163","author":"Chang","year":"2022","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2024.05.004_bib0070","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1053\/j.gastro.2020.05.059","article-title":"AGA clinical practice guidelines on the role of probiotics in the management of gastrointestinal disorders","volume":"159","author":"Su","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2024.05.004_bib0071","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1007\/s12664-018-0894-1","article-title":"Indian consensus on chronic constipation in adults: a joint position statement of the Indian Motility and Functional Diseases Association and the Indian Society of Gastroenterology","volume":"37","author":"Ghoshal","year":"2018","journal-title":"Indian J Gastroenterol"},{"key":"10.1016\/j.dld.2024.05.004_bib0072","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s00535-020-01746-z","article-title":"Evidence-based clinical practice guidelines for irritable bowel syndrome 2020","volume":"56","author":"Fukudo","year":"2021","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.dld.2024.05.004_bib0073","doi-asserted-by":"crossref","DOI":"10.14309\/ctg.0000000000000060","article-title":"A low FODMAP diet may reduce symptoms in patients with fecal incontinence","volume":"10","author":"Menees","year":"2019","journal-title":"Clin Transl Gastroenterol"},{"key":"10.1016\/j.dld.2024.05.004_bib0074","article-title":"Green kiwifruit (lat. Actinidia deliciosa var. Hayward) and maintenance of normal defecation: evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924\/2006","volume":"19","author":"Turck","year":"2021","journal-title":"EFSA J"},{"key":"10.1016\/j.dld.2024.05.004_bib0075","doi-asserted-by":"crossref","DOI":"10.1111\/nmo.13874","article-title":"The effect of green kiwifruit on gas transit and tolerance in healthy humans","volume":"32","author":"Caballero","year":"2020","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.dld.2024.05.004_bib0076","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.14309\/ajg.0000000000002124","article-title":"Consumption of 2 green kiwifruits daily improves constipation and abdominal comfort-results of an international multicenter randomized controlled trial","volume":"118","author":"Gearry","year":"2023","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2024.05.004_bib0077","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1093\/advances\/nmac025","article-title":"Habitual green kiwifruit consumption is associated with a reduction in upper gastrointestinal symptoms: a systematic scoping review","volume":"13","author":"Bayer","year":"2022","journal-title":"Adv Nutr"},{"key":"10.1016\/j.dld.2024.05.004_bib0078","article-title":"Systematic review and meta-analysis: foods, drinks and diets and their effect on chronic constipation in adults","author":"Van Der Schoot","year":"2023","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2024.05.004_bib0079","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2020.00023","article-title":"The role of diet in functional dyspepsia management","volume":"11","author":"Duboc","year":"2020","journal-title":"Front Psychiatry"},{"key":"10.1016\/j.dld.2024.05.004_bib0080","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/jgh.15694","article-title":"Low fermentable oligosaccharides, disaccharides, monosaccharides, and polyols diet versus traditional dietary advice for functional dyspepsia: a randomized controlled trial","volume":"37","author":"Goyal","year":"2022","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2024.05.004_bib0081","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.trsl.2016.10.002","article-title":"Feeding the microbiota-gut-brain axis: diet, microbiome, and neuropsychiatry","volume":"179","author":"Sandhu","year":"2017","journal-title":"Transl Res"},{"key":"10.1016\/j.dld.2024.05.004_bib0082","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/nrgastro.2017.75","article-title":"Expert consensus document: the International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics","volume":"14","author":"Gibson","year":"2017","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2024.05.004_bib0083","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.coph.2018.08.010","article-title":"Pre- and probiotic overview","volume":"43","author":"Cremon","year":"2018","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.dld.2024.05.004_bib0084","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1017\/S0007114508960918","article-title":"Effect of a prebiotic mixture on intestinal comfort and general wellbeing in health","volume":"100","author":"Goetze","year":"2008","journal-title":"Br J Nutr"},{"key":"10.1016\/j.dld.2024.05.004_bib0085","doi-asserted-by":"crossref","first-page":"e12969","DOI":"10.1111\/nmo.12969","article-title":"Effects of varying dietary content of fermentable short-chain carbohydrates on symptoms, fecal microenvironment, and cytokine profiles in patients with irritable bowel syndrome","volume":"29","author":"Hustoft","year":"2017","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.dld.2024.05.004_bib0086","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1111\/j.1365-2036.2008.03911.x","article-title":"Clinical trial: the effects of a trans-galactooligosaccharide prebiotic on faecal microbiota and symptoms in irritable bowel syndrome","volume":"29","author":"Silk","year":"2009","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2024.05.004_bib0087","doi-asserted-by":"crossref","DOI":"10.1111\/nmo.13440","article-title":"Effect of a prebiotic galactooligosaccharide mixture (B-GOS\u00ae) on gastrointestinal symptoms in adults selected from a general population who suffer with bloating, abdominal pain, or flatulence","volume":"30","author":"Vulevic","year":"2018","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.dld.2024.05.004_bib0088","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1053\/j.gastro.2018.06.045","article-title":"Effects of prebiotics vs a diet low in fodmaps in patients with functional gut disorders","volume":"155","author":"Huaman","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2024.05.004_bib0089","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00394-002-1103-6","article-title":"Medical, nutritional and technological properties of lactulose. An update","volume":"41","author":"Schumann","year":"2002","journal-title":"Eur J Nutr"},{"key":"10.1016\/j.dld.2024.05.004_bib0090","doi-asserted-by":"crossref","first-page":"e12911","DOI":"10.1111\/nmo.12911","article-title":"Effects of scFOS on the composition of fecal microbiota and anxiety in patients with irritable bowel syndrome: a randomized, double blind, placebo controlled study","volume":"29","author":"Azpiroz","year":"2017","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.dld.2024.05.004_bib0091","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/nrgastro.2014.66","article-title":"Expert consensus document: the international scientific association for probiotics and prebiotics consensus statement on the scope and appropriate use of the term probiotic","volume":"11","author":"Hill","year":"2014","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2024.05.004_bib0092","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41395-018-0084-x","article-title":"American College of Gastroenterology Monograph on management of irritable bowel syndrome","volume":"113","author":"Ford","year":"2018","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2024.05.004_bib0093","article-title":"Systematic review and meta-analysis: efficacy of mesalamine in irritable bowel syndrome","author":"Goodoory","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2024.05.004_bib0094","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1177\/2050640617736478","article-title":"Effect of Lactobacillus paracasei CNCM I-1572 on symptoms, gut microbiota, short chain fatty acids, and immune activation in patients with irritable bowel syndrome: a pilot randomized clinical trial","volume":"6","author":"Cremon","year":"2018","journal-title":"United Eur Gastroenterol J"},{"key":"10.1016\/j.dld.2024.05.004_bib0095","doi-asserted-by":"crossref","first-page":"2696","DOI":"10.3748\/wjg.v23.i15.2696","article-title":"Effect of Lactobacillus rhamnosus HN001 and Bifidobacterium longum BB536 on the healthy gut microbiota composition at phyla and species level: a preliminary study basic study","volume":"23","author":"Toscano","year":"2017","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.dld.2024.05.004_bib0096","doi-asserted-by":"crossref","first-page":"e13201","DOI":"10.1111\/eci.13201","article-title":"Effects of Bifidobacterium longum BB536 and Lactobacillus rhamnosus HN001 in IBS patients","volume":"50","author":"Bonfrate","year":"2020","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.dld.2024.05.004_bib0097","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2023.2298246","article-title":"Collinsella aerofaciens as a predictive marker of response to probiotic treatment in non-constipated irritable bowel syndrome","volume":"16","author":"Gargari","year":"2024","journal-title":"Gut Microbes"},{"key":"10.1016\/j.dld.2024.05.004_bib0098","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1007\/s12272-014-0522-2","article-title":"Effect of a double-coated probiotic formulation on functional constipation in the elderly: a randomized, double blind, controlled study","volume":"38","author":"Yeun","year":"2015","journal-title":"Arch Pharm Res"},{"key":"10.1016\/j.dld.2024.05.004_bib0099","doi-asserted-by":"crossref","first-page":"387","DOI":"10.15403\/jgld.2014.1121.234.elr","article-title":"The effect of Lactobacillus reuteri supplementation in adults with chronic functional constipation: a randomized, double-blind, placebo-controlled trial","volume":"23","author":"Ojetti","year":"2014","journal-title":"J Gastrointestin Liver Dis"},{"key":"10.1016\/j.dld.2024.05.004_bib0100","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3920\/BM2017.0049","article-title":"Randomised double blind placebo controlled trial on Lactobacillus reuteri DSM 17938: improvement in symptoms and bowel habit in functional constipation","volume":"9","author":"Riezzo","year":"2018","journal-title":"Benef Microbes"},{"key":"10.1016\/j.dld.2024.05.004_bib0101","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1080\/19490976.2017.1412908","article-title":"Effects of 28-day Bifidobacterium animalis subsp. lactis HN019 supplementation on colonic transit time and gastrointestinal symptoms in adults with functional constipation: a double-blind, randomized, placebo-controlled, and dose-ranging trial","volume":"9","author":"Ibarra","year":"2018","journal-title":"Gut Microbes"},{"key":"10.1016\/j.dld.2024.05.004_bib0102","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1080\/09637486.2017.1417977","article-title":"The effects of fermented milk containing Lactococcus lactis subsp. cremoris FC on defaecation in healthy young Japanese women: a double-blind, placebo-controlled study","volume":"69","author":"Ozaki","year":"2018","journal-title":"Int J Food Sci Nutr"},{"key":"10.1016\/j.dld.2024.05.004_bib0103","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/s41575-020-0344-2","article-title":"The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of synbiotics","volume":"17","author":"Swanson","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2024.05.004_bib0104","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.clnu.2012.08.010","article-title":"Effect of synbiotic in constipated adult women - a randomized, double-blind, placebo-controlled study of clinical response","volume":"32","author":"Waitzberg","year":"2013","journal-title":"Clin Nutr"},{"key":"10.1016\/j.dld.2024.05.004_bib0105","doi-asserted-by":"crossref","first-page":"605","DOI":"10.3390\/nu8100605","article-title":"Efficacy of synbiotics in patients with slow transit constipation: a prospective randomized trial","volume":"8","author":"Ding","year":"2016","journal-title":"Nutrients"},{"key":"10.1016\/j.dld.2024.05.004_bib0106","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s12602-020-09681-4","article-title":"Effect of multi-strain probiotic formulation on students facing examination stress: a double-blind, placebo-controlled study","volume":"13","author":"Venkataraman","year":"2021","journal-title":"Probiot Antimicrob Proteins"},{"key":"10.1016\/j.dld.2024.05.004_bib0107","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0244680","article-title":"Multi-strain probiotics (Hexbio) containing MCP BCMC strains improved constipation and gut motility in Parkinson\u2019s disease: A randomised controlled trial","volume":"15","author":"Ibrahim","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.dld.2024.05.004_bib0108","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/s41575-021-00440-6","article-title":"The International Scientific Association of Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of postbiotics","volume":"18","author":"Salminen","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2024.05.004_bib0109","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/S2468-1253(20)30056-X","article-title":"Heat-inactivated Bifidobacterium bifidum MIMBb75 (SYN-HI-001) in the treatment of irritable bowel syndrome: a multicentre, randomised, double-blind, placebo-controlled clinical trial","volume":"5","author":"Andresen","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2024.05.004_bib0110","doi-asserted-by":"crossref","DOI":"10.1128\/cmr.00039-23","article-title":"The potential for development of clinically relevant microbial resistance to rifaximin-\u03b1: a narrative review","volume":"36","author":"DuPont","year":"2023","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.dld.2024.05.004_bib0111","doi-asserted-by":"crossref","DOI":"10.1177\/1756284819897531","article-title":"Mechanism of action and therapeutic benefit of rifaximin in patients with irritable bowel syndrome: a narrative review","volume":"13","author":"Chey","year":"2020","journal-title":"Therap Adv Gastroenterol"},{"key":"10.1016\/j.dld.2024.05.004_bib0112","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/0005-2787(67)90147-5","article-title":"The specific inhibition of the DNA-directed RNA synthesis by rifamycin","volume":"145","author":"Hartmann","year":"1967","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.dld.2024.05.004_bib0113","doi-asserted-by":"crossref","first-page":"519","DOI":"10.3920\/BM2019.0171","article-title":"Increased Faecalibacterium abundance is associated with clinical improvement in patients receiving rifaximin treatment","volume":"11","author":"Ponziani","year":"2020","journal-title":"Benef Microbes"},{"key":"10.1016\/j.dld.2024.05.004_bib0114","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1124\/jpet.107.121913","article-title":"Rifaximin is a gut-specific human pregnane X receptor activator","volume":"322","author":"Ma","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.dld.2024.05.004_bib0115","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1056\/NEJMoa1004409","article-title":"Rifaximin therapy for patients with irritable bowel syndrome without constipation","volume":"364","author":"Pimentel","year":"2011","journal-title":"N Eng J Med"},{"key":"10.1016\/j.dld.2024.05.004_bib0116","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1053\/j.gastro.2016.08.003","article-title":"Repeat treatment with rifaximin is safe and effective in patients with diarrhea-predominant irritable bowel syndrome","volume":"151","author":"Lembo","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2024.05.004_bib0117","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1111\/apt.12735","article-title":"Safety and tolerability of rifaximin for the treatment of irritable bowel syndrome without constipation: a pooled analysis of randomised, double-blind, placebo-controlled trials","volume":"39","author":"Schoenfeld","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2024.05.004_bib0118","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.amjmed.2011.08.026","article-title":"Evaluation of harm in the pharmacotherapy of irritable bowel syndrome","volume":"125","author":"Shah","year":"2012","journal-title":"Am J Med"},{"key":"10.1016\/j.dld.2024.05.004_bib0119","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1111\/apt.13945","article-title":"Randomised clinical trial: rifaximin versus placebo for the treatment of functional dyspepsia","volume":"45","author":"Tan","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2024.05.004_bib0120","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1007\/s10620-021-07149-1","article-title":"Concomitant irritable bowel syndrome does not influence the response to antimicrobial therapy in patients with functional dyspepsia","volume":"67","author":"Shah","year":"2022","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.dld.2024.05.004_bib0121","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1136\/gutjnl-2019-320411","article-title":"Faecal microbial transplantation in IBS: ready for prime time?","volume":"69","author":"Barbara","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.dld.2024.05.004_bib0122","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.jad.2018.04.038","article-title":"The effect of fecal microbiota transplantation on psychiatric symptoms among patients with irritable bowel syndrome, functional diarrhea and functional constipation: an open-label observational study","volume":"235","author":"Kurokawa","year":"2018","journal-title":"J Affect Disord"},{"issue":"8","key":"10.1016\/j.dld.2024.05.004_bib0123","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1177\/2050640619866990","article-title":"Fecal microbiota transplantation in irritable bowel syndrome: A systematic review and meta-analysis","volume":"7","author":"Myneedu","year":"2019","journal-title":"United European Gastroenterol J"},{"key":"10.1016\/j.dld.2024.05.004_bib0124","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/apt.15330","article-title":"Systematic review with meta-analysis: efficacy of faecal microbiota transplantation for the treatment of irritable bowel syndrome","volume":"50","author":"Ianiro","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2024.05.004_bib0125","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241914562","article-title":"Fecal microbiota transplantation in irritable bowel syndrome: a systematic review and meta-analysis of randomized controlled trials","volume":"24","author":"Jamshidi","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.dld.2024.05.004_bib0126","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1136\/gutjnl-2019-319630","article-title":"Efficacy of faecal microbiota transplantation for patients with irritable bowel syndrome in a randomised, double-blind, placebo-controlled study","volume":"69","author":"El-Salhy","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.dld.2024.05.004_bib0127","article-title":"Fecal microbiota transplantation modulates the gut flora favoring patients with functional constipation","volume":"12","author":"Zhang","year":"2021","journal-title":"Front Microbiol"},{"key":"10.1016\/j.dld.2024.05.004_bib0128","doi-asserted-by":"crossref","DOI":"10.1177\/1756284820968423","article-title":"Potential role of fecal microbiota in patients with constipation","volume":"13","author":"Tian","year":"2020","journal-title":"Therap Adv Gastroenterol"},{"key":"10.1016\/j.dld.2024.05.004_bib0129","doi-asserted-by":"crossref","DOI":"10.1186\/s12866-023-03123-1","article-title":"Multi-omics analysis of fecal microbiota transplantation's impact on functional constipation and comorbid depression and anxiety","volume":"23","author":"Yang","year":"2023","journal-title":"BMC Microbiol"}],"container-title":["Digestive and Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865824007424?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865824007424?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,25]],"date-time":"2024-11-25T09:44:38Z","timestamp":1732527878000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1590865824007424"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":129,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S1590865824007424"],"URL":"https:\/\/doi.org\/10.1016\/j.dld.2024.05.004","relation":{},"ISSN":["1590-8658"],"issn-type":[{"value":"1590-8658","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Microbiota modulation in disorders of gut-brain interaction","name":"articletitle","label":"Article Title"},{"value":"Digestive and Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dld.2024.05.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Ltd on behalf of Editrice Gastroenterologica Italiana S.r.l.","name":"copyright","label":"Copyright"}]}}